Basilea Pharmaceutica
BSLN.SW
#6323
Rank
A$0.98 B
Marketcap
$81.25
Share price
2.38%
Change (1 day)
16.54%
Change (1 year)

EPS for Basilea Pharmaceutica (BSLN.SW)

EPS in 2023: $1.62

According to Basilea Pharmaceutica's latest financial reports the company's current EPS (TTM) is $1.62. In 2023 the company made an earnings per share (EPS) of $1.62 a decrease over its 2022 EPS that were of $1.72.

EPS history for Basilea Pharmaceutica from 2002 to 2023

Annual EPS

Year EPS Change
2023$1.62-6.28%
2022$1.72-273.94%
2021-$0.99-60.87%
2020-$2.53-24.46%
2019-$3.35-26.92%
2018-$4.5959.83%
2017-$2.87-63.06%
2016-$7.77-19.26%
2015-$9.6346.12%
2014-$6.5910.07%
2013-$5.99-36.76%
2012-$9.46-5.42%
2011-$10.01-153.36%
2010$18.75-198.47%
2009-$19.04-15.34%
2008-$22.4916.7%
2007-$19.2736.07%
2006-$14.1679.07%
2005-$7.91-46.79%
2004-$14.869.83%
2003-$13.53-34.23%
2002-$20.58